Keyphrases
Aldose Reductase Inhibitor
100%
Fidarestat
100%
Endothelial Cell Death
100%
Doxorubicin
100%
Induced Endothelial Cells
100%
Endothelial Cell Dysfunction
100%
Human Umbilical Vein Endothelial Cells (HUVECs)
38%
Cardiotoxicity
23%
Inflammatory Cytokines
15%
Inflammatory Chemokines
15%
Endothelial Nitric Oxide Synthase (eNOS)
15%
Breast Cancer
7%
Inducible Nitric Oxide Synthase
7%
Endothelial Dysfunction
7%
Reactive Oxygen Species
7%
Cardiomyopathy
7%
Colon Cancer Cells
7%
Aorta
7%
Colon Cancer
7%
Cell Toxicity
7%
High Dose
7%
Adjuvant Therapy
7%
Tyrosine
7%
Cytotoxicity
7%
Intercellular Adhesion molecule-1 (ICAM-1)
7%
Vascular Cell Adhesion molecule-1 (VCAM-1)
7%
Lung Cancer
7%
Induced Expression
7%
Drug Resistance
7%
NF-B
7%
Cellular Expression
7%
Cell Dysfunction
7%
Induced Oxidative Stress
7%
Incubation
7%
Cardiac Cells
7%
Caspase-3
7%
Cardiovascular Complications
7%
Cancer Cell Death
7%
Anthracycline Chemotherapy
7%
Chemotherapy Agents
7%
Chemotherapy Efficacy
7%
Nitric Oxide Level
7%
Monocyte Adhesion
7%
AR Inhibitors
7%
Oxygen Activation
7%
Cell Hypertrophy
7%
Blood Cancer
7%
Immunology and Microbiology
Cell Death
100%
Umbilical Vein Endothelial Cell
100%
Pretreatment
60%
Colon
40%
Chemokine
40%
Cytotoxicity
40%
Inflammatory Cytokine
40%
Cancer Cell
20%
Oxidative Stress
20%
Caspase
20%
VCAM-1
20%
Drug Megadose
20%
Drug Resistance
20%
Intercellular Adhesion Molecule 1
20%
In Vitro
20%
Pharmacology, Toxicology and Pharmaceutical Science
Aldose Reductase Inhibitor
100%
Fidarestat
100%
Doxorubicin
100%
Cytokine
15%
Chemokine
15%
Cardiotoxicity
15%
Colon Carcinoma
15%
Cytotoxicity
15%
Reactive Oxygen Metabolite
7%
Chemotherapy
7%
Nitric Oxide
7%
Vascular Cell Adhesion Molecule 1
7%
Lung Cancer
7%
Breast Cancer
7%
Caspase 3
7%
Drug Resistance
7%
Endothelial Dysfunction
7%
Intercellular Adhesion Molecule 1
7%
3 Nitrotyrosine
7%
Anthracycline
7%
Chemotherapy Agent
7%
Myocardial Disease
7%
Cardiovascular Disease
7%
Side Effect
7%
Biochemistry, Genetics and Molecular Biology
Cell Death
100%
Aldose Reductase Inhibitor
100%
Doxorubicin
100%
Colon
15%
Cytotoxicity
15%
Chemokine
15%
Inflammatory Cytokine
15%
Cancer Cell
7%
Oxidative Stress
7%
Nitric Oxide
7%
VCAM-1
7%
Drug Megadose
7%
ICAM-1
7%
Caspase 3
7%
Drug Resistance
7%
Anthracycline
7%